1. Doxorubicin and adjudin co-loaded pH-sensitive nanoparticles for the treatment of drug-resistant cancer. (August 2019) Authors: Wang, Qiong; Zou, Chenming; Wang, Lingying; Gao, Xueqin; Wu, Jindan; Tan, Songwei; Wu, Gang Journal: Acta biomaterialia Issue: Volume 94(2019) Page Start: 469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Interleukin‐6 receptor alpha and CD27 discriminate intratumoral T helper 17 subpopulations with distinct functional properties in a mouse lung cancer model. Issue 4 (27th September 2021) Authors: Liu, Chong; Xiong, Fei; Wang, Lingying; Chen, Kang; Wu, Pingshang; Hua, Li; Zhang, Zhuo Journal: Immunity, inflammation and disease Issue: Volume 9:Issue 4(2021) Page Start: 1749 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. KIF23 promotes autophagy‐induced imatinib resistance in chronic myeloid leukaemia through activating Wnt/β‐catenin pathway. (29th September 2022) Authors: Huang, Yong; Yuan, Chunyan; Liu, Qiwei; Wang, Lingying Journal: Clinical and experimental pharmacology and physiology Issue: Volume 49:Number 12(2022) Page Start: 1334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Zerumbone‐induced reactive oxygen species‐mediated oxidative stress re‐sensitizes breast cancer cells to paclitaxel. (25th March 2022) Authors: Li, Jutao; Wang, Lingying; Sun, Yuxin; Wang, Zhe; Qian, Ye; Duraisamy, Vidhya; Antary, Tawfiq M. Al Journal: Biotechnology and applied biochemistry Issue: Volume 70:Number 1(2023) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗